WO2004032856A3 - Composes - Google Patents

Composes Download PDF

Info

Publication number
WO2004032856A3
WO2004032856A3 PCT/US2003/031795 US0331795W WO2004032856A3 WO 2004032856 A3 WO2004032856 A3 WO 2004032856A3 US 0331795 W US0331795 W US 0331795W WO 2004032856 A3 WO2004032856 A3 WO 2004032856A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
ccr8
oxazolidin
nominated
asthma
Prior art date
Application number
PCT/US2003/031795
Other languages
English (en)
Other versions
WO2004032856A2 (fr
Inventor
Jian Jin
Jeffrey K Kerns
Feng Wang
Yonghui Wang
Original Assignee
Smithkline Beecham Corp
Jian Jin
Jeffrey K Kerns
Feng Wang
Yonghui Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Jian Jin, Jeffrey K Kerns, Feng Wang, Yonghui Wang filed Critical Smithkline Beecham Corp
Priority to AU2003275480A priority Critical patent/AU2003275480A1/en
Publication of WO2004032856A2 publication Critical patent/WO2004032856A2/fr
Publication of WO2004032856A3 publication Critical patent/WO2004032856A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne une oxazolidin-2-one de formule (I) telle que définie dans la description. Ce composé sert à inhiber le récepteur CCR8 des chimiokines et permet de ce fait de traiter des maladies telles que l'asthme ou des maladies analogues.
PCT/US2003/031795 2002-10-07 2003-10-07 Composes WO2004032856A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003275480A AU2003275480A1 (en) 2002-10-07 2003-10-07 Compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41681802P 2002-10-07 2002-10-07
US60/416818 2002-10-07

Publications (2)

Publication Number Publication Date
WO2004032856A2 WO2004032856A2 (fr) 2004-04-22
WO2004032856A3 true WO2004032856A3 (fr) 2007-11-15

Family

ID=32093904

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/031795 WO2004032856A2 (fr) 2002-10-07 2003-10-07 Composes

Country Status (2)

Country Link
AU (1) AU2003275480A1 (fr)
WO (1) WO2004032856A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099165A1 (fr) * 2007-02-15 2008-08-21 Astrazeneca Ab Dérivés de pipéridine et leur utilisation pour le traitement de maladies à médiation par ccr8
MX2010006111A (es) 2007-12-18 2010-06-25 Actelion Pharmaceuticals Ltd Derivados de 5-aminociclilmetil-oxazolidin-2-ona y su uso como antibacteriales.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776937A (en) * 1994-11-08 1998-07-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Adhesion receptor antagonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776937A (en) * 1994-11-08 1998-07-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Adhesion receptor antagonists

Also Published As

Publication number Publication date
AU2003275480A1 (en) 2004-05-04
WO2004032856A2 (fr) 2004-04-22
AU2003275480A8 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
WO2004006858A3 (fr) Composes, compositions et methodes d'utilisation de ces derniers
AU2003281978A1 (en) 2,5-diketopiperazines for the treatment of obesity
WO2004103960A3 (fr) Composes et utilisations de ces derniers
EP1485381B8 (fr) Azolylaminoazines en tant qu'inhibiteurs de proteines kinases
WO2005011592A3 (fr) Indazoles-o-glucosides substitues
WO2005012243A3 (fr) Indole-o-glucosides substitues
WO2005046603A3 (fr) Composes pyridiniques
WO2004011611A3 (fr) Anticorps anti-taci et utilisations de ceux-ci
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
WO2003082208A8 (fr) Composes de pyrrolopyridazine et methodes d'utilisation de ces composes pour le traitement de maladies proliferatives
WO2004069152A3 (fr) ?4,5 glycuronidase et ses utilisations
AU2003289888A1 (en) Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
WO2006009765A3 (fr) Procedes d'identification et d'utilisation de composes adaptes au traitement de cellules cancereuses resistantes aux medicaments
AU2003280298A1 (en) Methods for the biological treatment of gas
AU2003242046A1 (en) Sustained-release composition, process for producing the same and preparation thereof
WO2003099217A3 (fr) Methodes de traitement d'infections bacteriennes et de maladies associees
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003203170A1 (en) Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
WO2004043379A3 (fr) Composes chimiques
AU2003245040A1 (en) Process for purifying pentafluoroethane, process for producing the same, and use thereof
WO2004019879A3 (fr) Composes du type motilide
AU2003247279A1 (en) Furancarboxamides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AU BA BB BR BZ CA CN CO CR CU DM DZ EC EG GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ OM PH PL RO SC SG TN TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP